How is tx of hepatic uncommon primary tumors?

TREATMENT Surgical resection for localized tumor. Contraindications: poor liver function, extrahepatic disease, diffuse hepatic disease. Medications: chemotherapy for unresectable lesions. PROGNOSIS resectable cholangiocarcinoma has 5-year survival of 15–20%; angiosarcoma has very poor prognosis; hepatoblastoma has overall survival of 50%.